SCHEMBL7307295

SCHEMBL7307295

CCCCc1nc(C(C)O)c(C(=O)OCC)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 5/20 0.60
AGTR2 P50052 5/20 0.60
PPARG P37231 1/20 0.51
KCNH2 Q12809 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7302931 0.95 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL7302526 0.91 AGTR1 (0.57) AGTR1AGTR2PPARG
SCHEMBL7910642 0.91 AGTR1 (0.50) AGTR1AGTR2PPARGKCNH2
SCHEMBL7900938 0.89 AGTR2 (0.57) AGTR1AGTR2PPARGKCNH2
SCHEMBL12991377 0.89 AGTR1 (0.64) AGTR1AGTR2
SCHEMBL13330206 0.88 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL13449209 0.87 AGTR1 (0.62) AGTR1AGTR2
SCHEMBL8823531 0.87 AGTR1 (0.61) AGTR1AGTR2
SCHEMBL684076 0.86 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL13449211 0.86 AGTR1 (0.60) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0545912-B1 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-04-25 EP disclosed
US-5646171-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1997-07-08 US disclosed
US-5616599-A HYPOTENSIVE AGENTS FOR CARDIOVASCULAR DISORDER SANKYO COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0545912-A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1993-06-09 EP disclosed
EP-0503785-A1 1-Biphenylimidazole derivatives, their preparation and their therapeutic use Sankyo Company Limited (JP) 1992-09-16 EP disclosed